Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

LBPH

Longboard Pharmaceuticals (LBPH)

Longboard Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:LBPH
DateTimeSourceHeadlineSymbolCompany
25/05/202406:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:LBPHLongboard Pharmaceuticals Inc
25/05/202406:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LBPHLongboard Pharmaceuticals Inc
07/05/202406:01Business WireLongboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)NASDAQ:LBPHLongboard Pharmaceuticals Inc
03/05/202406:01Business WireLongboard Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate UpdatesNASDAQ:LBPHLongboard Pharmaceuticals Inc
04/04/202400:00Business WireLongboard Pharmaceuticals to Present Late-Breaking Data from the PACIFIC Study at the American Academy of Neurology (AAN) Annual Meeting on April 15NASDAQ:LBPHLongboard Pharmaceuticals Inc
03/04/202407:00Business WireLongboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)NASDAQ:LBPHLongboard Pharmaceuticals Inc
13/03/202407:01Business WireLongboard Pharmaceuticals Reports Full Year 2023 Financial Results and Provides Corporate UpdatesNASDAQ:LBPHLongboard Pharmaceuticals Inc
02/03/202408:01Business WireLongboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)NASDAQ:LBPHLongboard Pharmaceuticals Inc
03/02/202408:30Business WireLongboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)NASDAQ:LBPHLongboard Pharmaceuticals Inc
02/02/202400:30Business WireLongboard Pharmaceuticals to Present at Two Upcoming Investor Conferences in FebruaryNASDAQ:LBPHLongboard Pharmaceuticals Inc
09/01/202408:05Business WireLongboard Pharmaceuticals Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional SharesNASDAQ:LBPHLongboard Pharmaceuticals Inc
05/01/202408:51Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LBPHLongboard Pharmaceuticals Inc
05/01/202408:48Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:LBPHLongboard Pharmaceuticals Inc
04/01/202413:40Business WireLongboard Pharmaceuticals Announces Pricing of Upsized Public Offering of Common StockNASDAQ:LBPHLongboard Pharmaceuticals Inc
04/01/202412:59Edgar (US Regulatory)Form S-3MEF - Registration adding securities to prior Form S-3 registration [Rule 462(b)]NASDAQ:LBPHLongboard Pharmaceuticals Inc
03/01/202408:54Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:LBPHLongboard Pharmaceuticals Inc
03/01/202408:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LBPHLongboard Pharmaceuticals Inc
03/01/202408:01Business WireLongboard Pharmaceuticals Announces Commencement of Public Offering of Common StockNASDAQ:LBPHLongboard Pharmaceuticals Inc
03/01/202401:44Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LBPHLongboard Pharmaceuticals Inc
03/01/202400:00Business WireLongboard Pharmaceuticals Announces Positive Topline Data from the PACIFIC Study, a Phase 1b/2a Clinical Trial, for Bexicaserin (LP352) in Participants with Developmental and Epileptic Encephalopathies (DEEs)NASDAQ:LBPHLongboard Pharmaceuticals Inc
02/01/202408:47Business WireLongboard Pharmaceuticals to Host Call to Discuss Topline Data from the PACIFIC Study, a Phase 1b/2a Clinical Trial for Bexicaserin (LP352) in Participants with Developmental and Epileptic Encephalopathies (DEEs)NASDAQ:LBPHLongboard Pharmaceuticals Inc
30/11/202300:35Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LBPHLongboard Pharmaceuticals Inc
30/11/202300:30Business WireLongboard Pharmaceuticals Announces Initiation of First-in-Human Phase 1 Clinical Study of LP659 in Adult Healthy VolunteersNASDAQ:LBPHLongboard Pharmaceuticals Inc
22/11/202308:00Business WireLongboard Pharmaceuticals’ Presence at American Epilepsy Society (AES) Annual Meeting Reinforces Ongoing Commitment to the Rare Epilepsy CommunityNASDAQ:LBPHLongboard Pharmaceuticals Inc
04/11/202307:01Business WireLongboard Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:LBPHLongboard Pharmaceuticals Inc
03/11/202307:15Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:LBPHLongboard Pharmaceuticals Inc
03/11/202307:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LBPHLongboard Pharmaceuticals Inc
03/11/202307:01Business WireLongboard Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2023 Financial ResultsNASDAQ:LBPHLongboard Pharmaceuticals Inc
01/11/202323:30Business WireLongboard Pharmaceuticals to Present at Three Upcoming Investor Conferences in NovemberNASDAQ:LBPHLongboard Pharmaceuticals Inc
12/10/202300:26Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:LBPHLongboard Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:LBPH